In today’s hyper-connected financial ecosystem, digital resilience has become the cornerstone of customer trust and sustained competitive advantage. Every interaction — from instant UPI payments to real-time loan approvals — demands flawless performance. Even a brief disruption can undermine confidence and impact customer relationships.
We are pleased to invite you to an exclusive webinar titled “AI-Powered Observability: The Next Frontier in BFSI Digital Resilience,” where experts will discuss how AI-driven observability is enabling financial institutions to build proactive, end-to-end resilience across applications, APIs, and partner ecosystems.
Dr. Uday Kulkarni Co-chair, Education and Training Committee, IACGT
Dr. Lakshmikanth Gandikota Chief Scientific Officer, Immuneel Therapeutics Private Limited Bengaluru, India , Chief Scientific Officer, Immuneel Therapeutics Private Limited Bengaluru, India
Dr. Joseph Melenhorst Vice Chair, Center for Immunotherapy & Precision Immuno-Oncology Director , Cell Therapy & Immuno-Engineering Program, Ohio, USA
Dr. Lakshmikanth Gandikota Chief Scientific Officer, Immuneel Therapeutics Private Limited Bengaluru, India , Chief Scientific Officer, Immuneel Therapeutics Private Limited Bengaluru, India
Dr. Arun kumar Associate Professor , Department of Haematology, Christian Medical College, Vellore, India
Dr. Gaurav Kharya Co-Founder I Director , Cellogen Therapeutics Pvt Ltd, Director I Center For Bone Marrow Transplant & Cellular Therapy, Senior Consultant I Pediatric Hematology Oncology & Immunology, Apollo Hospital Delhi
Dr. Albeena Nisar Lead Scientist, CAR T Cell Therapy Centre , Advanced Centre for Treatment & Research in Education, TMC, Mumbai, India
Dr. Joseph Melenhorst Vice Chair, Center for Immunotherapy & Precision Immuno-Oncology , Director, Cell Therapy & Immuno-Engineering Program, Ohio, USA
Dr Shaji R Velayudhan Co-chair, Education and Training Committee, IACGT


















Become a Member of IACGT Click Here